
Pioneering Cancer Diagnostics
and Therapies
At L’Ord’invent Limited, we are committed to innovating cancer diagnostics and therapies to significantly prolong the survival and saving millions of lives of cancer patients while keeping the side effects minimal and preserving quality of life.
News


Showcasing our Organiser's Choice Innovations at HKU Innovation Week cum Award Ceremony


Showcasing our Patented Inventions in Asia Summit on Global Health 2025


Winning Gold Medal at Geneva Exhibition of Inventions 2025: Revolutionizing Radioligand Therapy
Co-Founders
L'Ord'invent Limited is a spin-off of Health@InnoHK R&D centre Laboratory for Synthetic Chemistry and Chemical Biology Limited

Prof Victor Ho-Fun Lee
Managing Director
L'Ord'invent Limited
​
Clinical Professor
Department Chairperson
Department of Clinical Oncology
Centre of Cancer Medicine
School of Clinical Medicine
LKS Faculty of Medicine
The University of Hong Kong
​
Expertise:​
(1) World-renowned board-certified clinical oncologist
(2) Enormous experience in diagnostics and therapeutics development, conducting investigator-initiated and drug-sponsored trials and has published extensively in this field.​​​​
​

Dr Eymon Ka-Chun Wu
Director
L'Ord'invent Limited
​
Postdoctoral Fellow
Department of Clinical Oncology
Centre of Cancer Medicine
School of Clinical Medicine
LKS Faculty of Medicine
The University of Hong Kong​
​
Expertise:
(1) Experienced in biomarker discovery using cutting-edge single-cell omics technology, diagnostics and therapeutic development, and have published extensively in this field.
​​
​
​
​

Laboratory of Synthetic Chemistry and Chemical Biology
Health@InnoHK
​
Founded in 2020, the Laboratory for Synthetic Chemistry and Chemical Biology Limited (LSCCB) is a collaborative initiative involving The University of Hong Kong, Imperial College London, the University of Oxford, and Peking University. Its mission is to integrate Chemical Science and Biomedical Science, focusing on the development of new synthetic chemistry, anticancer medications, and the chemical biology of traditional Chinese medicines to combat some of the most challenging cancers.
​
​​​​​
​

Key Innovations

Watch Now

